PER
Click for more information
1.19% 8.5¢ percheron therapeutics limited

atl1103 anti cancer medications, page-107

  1. wormy
    2,405 Posts.
    clock Created with Sketch.
    17/11/11
    18:18
    Post #: 9302597
    dont forget holders =


    2 trails under way at same time for ATL1103 =Mattel Children?s Hospital at UCLA Los Angeles, CA 90095 /Austin Hospital, Heidelberg, Victoria


    Antisense said would conduct its ATL1103 cancer experimental program in parallel with the phase I acromegaly clinical trial, established with Mattel
    Children?s Hospital at UCLA head of diabetes and endocrinology


    (.>_<)
    ANP Price at posting: 21.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

ARU Cashed up Arafura locks in $171M German export agency deal; locks in NdPr offtake for wind turbines
right-arrow Created with Sketch.
LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
NEWS Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom
right-arrow Created with Sketch.
NEWS Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25
right-arrow Created with Sketch.
ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.5¢ 		Change
0.001(1.19%) 		Mkt cap ! $76.63M
Open High Low Value Volume
8.3¢ 8.5¢ 8.3¢ $32.58K 385.2K

Buyers (Bids)

No. Vol. Price($)
1 3647 8.4¢
 

Sellers (Offers)

Price($) Vol. No.
8.5¢ 8842 1
View Market Depth
Last trade - 16.10pm 04/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.